COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 22, 2021

Primary Completion Date

December 8, 2022

Study Completion Date

December 18, 2022

Conditions
Long COVID
Interventions
DIETARY_SUPPLEMENT

Echinochrome A

Dietary Supplement with Echinochroma A Simple randomized design, in this arm patients will take 6ml of a 0.025% Echinochroma A solution twice a day for 90 days. 3 mg of Echinochroma A will be consumed per day.

OTHER

Control

Simple randomized design, in this arm patients will take 6ml of an fructose aqueous solution twice a day for 90 days with the same flavor as the treatment

Trial Locations (1)

1408

Hospital Donación Francisco Santojanni, Buenos Aires

All Listed Sponsors
collaborator

Universidad Nacional de la Patagonia San Juan Bosco

UNKNOWN

collaborator

Ministerio de Ciencia, Tecnologia e Innovación, Argentina

UNKNOWN

collaborator

Hospital de Infecciosas Francisco Javier Muniz

OTHER_GOV

lead

Fernando Saldarini

OTHER

NCT05531019 - COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A | Biotech Hunter | Biotech Hunter